LASOCON ™

LASOCON 30 MG CAPSULE
Generic : Lansoprazole
Thearapeutic : Antiulcerant
Pack Size : 28s
Strength :
Dosage Form : Capsule

Lasocon

Lansoprazole

Composition

  • Lasocon 30 mg Capsule: Each capsule contains Lansoprazole USP 30 mg as enteric-coated pellets.
  • Pharmacology: Lansoprazole is a benzimidazole sulfoxide derivative that produces long-lasting inhibition of gastric acid secretion by inactivating parietal cell H+/K+ ATPase.

Lansoprazole is rapidly and extensively absorbed (85%) from the gastrointestinal tract when administered as enteric-coated granules. There is little or no pre-systemic metabolism. The absolute bioavailability of Lansoprazole from this form is 85% in healthy volunteers. Lansoprazole is rapidly distributed throughout the body with a small volume of distribution because it is completely bound to plasma protein. Lansoprazole is eliminated primarily by hepatic metabolism, the metabolites being excreted both via the bile and in urine.

Biopharma Ltd. Produces LASOCON 30 MG CAPSULE it is a trusted product for alleviating various discomforts, and it's commonly found in pharmacies and stores.

BIOPHARMA   AFFILIATE  COMPANIES